8/14/2013 7:33:51 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
China's Ministry of Commerce has approved Baxter International Inc's $4 billion bid for Sweden's Gambro AB provided Baxter sells its global continuous renal replacement therapy (CRRT) business, among other conditions. The U.S. dialysis equipment maker must also end an outsourcing production deal in China with Japan's Nipro Corporation by March 31, 2016. The approval is subject to corporate monitors as well, the ministry said.
Help employers find you! Check out all the jobs and post your resume.
comments powered by